| Day Low 09:46 AM EDT | 43.32 | |
|---|---|---|
| Day High 11:49 AM EDT | 43.70 |
|
| Range | 0.38 | |
| Volume | 1.73 M | |
| 30-Day Avg. Vol. | 1.63 M |
|
| Difference | 6.10% | |
| Market Cap. | 63.42 B | |
| Change | 1.61 B | |
| Shares Out. | 1.45 B | |
| Percent Traded | 0.12% | |
| Revenue | 29.55 B | |
| Earnings | 5.59 B | |
| EPS (TTM) | 3.75 |
| 52-Wk Low 3/17/08 | 35.03 | |
|---|---|---|
| 52-Wk High 7/13/07 | 56.60 |
|
| Range | 21.57 | |
| Prev. Close 5/15/08 | 42.45 | |
| Today's Open | 43.43 | |
| Change | 2.31% | |
| Dividend (TTM) | 1.87 | |
| Div. Yield (TTM) | 4.61% |
|
| Beta | 0.42 | |
| P/E Ratio (TTM) | 11.68 | |
| P/E Ratio (Fwd.) | — |
AstraZeneca's products run the gamut from A (breast cancer drug Arimidex) to Z (migraine treatment Zomig). One of the world's top pharmaceutical firms, AstraZeneca specializes in drugs for gastrointestinal, ... View Full Description
| Earnings/Share(EPS) | Estimate | Actual | Difference |
|---|---|---|---|
| 2 Quarters Ago | 0.94 12/31/07 | 1.10 12/31/07 |
0.15
Beat
|
| Last Quarter | 1.19 3/31/08 | 1.28 3/31/08 |
0.09
Beat
|
| Quarterly - 03/31/2008 | Annual - 2007 | |
|---|---|---|
| Total Revenue | 7.68 B | 29.56 B |
| Gross Profit | 6.18 B | 23.00 B |
| Operating Income | 2.17 B | 8.33 B |
| Net Income | 1.50 B | 5.60 B |
